-+ 0.00%
-+ 0.00%
-+ 0.00%

CRESCENT BIOPHARMA ANNOUNCES TRIAL IN PROGRESS PRESENTATION FOR ASCEND STUDY OF CR-001, A PD-1 X VEGF BISPECIFIC ANTIBODY, AT UPCOMING AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) 2026 ANNUAL MEETING

Reuters·05/21/2026 21:30:00

Please log in to view news